HP
HealthInvest Partners Portfolio holdings
AUM
$234M
This Quarter Return
+2.67%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$234M
AUM Growth
+$234M
(+3.2%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
6.93%
Top 10 Holdings %
Top 10 Hldgs %
56.95%
Holding
38
New
1
Increased
23
Reduced
13
Closed
1
Top Buys
| 1 |
Eli Lilly
LLY
|
$3.21M |
| 2 |
Stryker
SYK
|
$1.77M |
| 3 |
Intuitive Surgical
ISRG
|
$1.75M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.57M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
$1.51M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$2.18M |
| 2 |
Arcellx
ACLX
|
$1.21M |
| 3 |
Amgen
AMGN
|
$749K |
| 4 |
Boston Scientific
BSX
|
$654K |
| 5 |
Krystal Biotech
KRYS
|
$458K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $30.2M | 12.92% | 38,721 +4,119 | +12% | +$3.21M |
|
2
AbbVie
ABBV
$372B
| $16.1M | 6.91% | 86,933 -2,294 | -3% | -$426K |
|
|
3
Boston Scientific
BSX
$156B
| $13.6M | 5.8% | 126,185 -6,088 | -5% | -$654K |
|
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $11.1M | 4.75% | 88,392 +12,511 | +16% | +$1.57M |
|
5
Merck
MRK
$210B
| $11M | 4.72% | 139,172 +11,493 | +9% | +$910K |
|
|
6
Stryker
SYK
$150B
| $10.9M | 4.65% | 27,466 +4,468 | +19% | +$1.77M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $10.8M | 4.64% | 24,328 +1,520 | +7% | +$677K |
|
|
8
Intuitive Surgical
ISRG
$170B
| $10.1M | 4.32% | 18,559 +3,214 | +21% | +$1.75M |
|
9
Thermo Fisher Scientific
TMO
$186B
| $9.84M | 4.21% | 24,266 +1,409 | +6% | +$571K |
|
10
Cencora
COR
$56.5B
| $9.44M | 4.04% | 31,466 -87 | -0.3% | -$26.1K |
|
11
Gilead Sciences
GILD
$140B
| $8.11M | 3.47% | 73,165 -3,833 | -5% | -$425K |
|
12
BridgeBio Pharma
BBIO
$9.89B
| $7.15M | 3.06% | 165,480 +14,132 | +9% | +$610K |
|
|
13
Amgen
AMGN
$155B
| $6.67M | 2.86% | 23,894 -2,683 | -10% | -$749K |
|
14
Alkermes
ALKS
$4.78B
| $6.5M | 2.78% | 227,224 +12,446 | +6% | +$356K |
|
|
ONC
15
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $5.9M | 2.53% | 24,386 -755 | -3% | -$183K |
|
|
16
Mirum Pharmaceuticals
MIRM
$3.71B
| $5.44M | 2.33% | 106,912 +29,649 | +38% | +$1.51M |
|
17
UFP Technologies
UFPT
$1.62B
| $5.34M | 2.29% | 21,886 +627 | +3% | +$153K |
|
18
Cardinal Health
CAH
$35.5B
| $4.5M | 1.93% | 26,797 -891 | -3% | -$150K |
|
19
Edwards Lifesciences
EW
$47.8B
| $4.49M | 1.92% | 57,360 -2,336 | -4% | -$183K |
|
|
VRNA
20
Verona Pharma
VRNA
$9.16B
| $4.45M | 1.91% | 47,100 +12,410 | +36% | +$1.17M |
|
21
DexCom
DXCM
$29.5B
| $4.44M | 1.9% | 50,872 +5,031 | +11% | +$439K |
|
22
iRhythm Technologies
IRTC
$5.46B
| $3.9M | 1.67% | 25,302 +4,755 | +23% | +$732K |
|
23
Soleno Therapeutics
SLNO
$3.6B
| $3.4M | 1.45% | 40,532 +3,434 | +9% | +$288K |
|
24
Merus
MRUS
$4.98B
| $3.15M | 1.35% | 59,889 +24,597 | +70% | +$1.29M |
|
25
Revolution Medicines
RVMD
$7.1B
| $3.03M | 1.3% | 82,275 +27,314 | +50% | +$1M |
|